相似文献
1
The balancing act after pediatric venous thromboembolism.
Blood Adv. 2025 Aug 12;9(15):3905-3906. doi: 10.1182/bloodadvances.2025016871.
2
Venous thromboembolism prophylaxis in the pediatric trauma population.
J Pediatr Surg. 2013 Jun;48(6):1413-21. doi: 10.1016/j.jpedsurg.2013.02.059.
3
A systematic review and meta-analysis for the association between duration of anticoagulation therapy and the risk of venous thromboembolism in patients with lower limb superficial venous thrombosis.
J Vasc Surg Venous Lymphat Disord. 2024 Mar;12(2):101726. doi: 10.1016/j.jvsv.2023.101726. Epub 2023 Nov 24.
4
Waiting to initiate venous thromboembolism prophylaxis increases the incidence of venous thromboembolism in pediatric patients with traumatic bleeding.
J Trauma Acute Care Surg. 2025 Sep 1;99(3):382-386. doi: 10.1097/TA.0000000000004670. Epub 2025 Jun 13.
5
[Venous Thromboembolism in Pediatric Age: A 15 Year Retrospective Review].
Acta Med Port. 2018 Sep 28;31(9):489-495. doi: 10.20344/amp.9639.
6
How I approach pharmacological thromboprophylaxis in children.
Blood. 2025 May 22;145(21):2439-2446. doi: 10.1182/blood.2024026327.
7
Stop the Clot: A Quality Improvement Initiative to Reduce the Rate of Venous Thromboembolism in the PICU.
Pediatr Crit Care Med. 2025 Aug 7. doi: 10.1097/PCC.0000000000003809.
8
Venous thromboembolism in the setting of pediatric central diabetes insipidus: a systematic review of the literature and report of 2 cases.
J Neurosurg Pediatr. 2022 Feb 25;29(5):580-589. doi: 10.3171/2022.1.PEDS21469. Print 2022 May 1.
9
Impact of Embedding a Venous Thromboembolism Risk Assessment Model in the Electronic Health Record Versus Usual Care: A Cluster-Randomized Trial.
Circ Cardiovasc Qual Outcomes. 2025 Aug;18(8):e010359. doi: 10.1161/CIRCOUTCOMES.123.010359. Epub 2024 Feb 6.
10
Risk Factors for Venous Thromboembolism in Pediatric Trauma Patients and Validation of a Novel Scoring System: The Risk of Clots in Kids With Trauma Score.
Pediatr Crit Care Med. 2016 May;17(5):391-9. doi: 10.1097/PCC.0000000000000699.
本文引用的文献
1
Recurrent thrombosis and major bleeding in children treated for VTE.
Blood Adv. 2025 Aug 12;9(15):3824-3831. doi: 10.1182/bloodadvances.2025016135.
2
Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial.
Lancet Haematol. 2025 May;12(5):e357-e364. doi: 10.1016/S2352-3026(25)00067-5. Epub 2025 Apr 10.
3
Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis.
J Thromb Haemost. 2023 Jun;21(6):1666-1673. doi: 10.1016/j.jtha.2023.03.004. Epub 2023 Mar 14.
4
High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
J Thromb Haemost. 2023 Jan;21(1):47-56. doi: 10.1016/j.jtha.2022.11.031. Epub 2022 Dec 22.
5
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182.
6
Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis.
Blood. 2022 Jan 20;139(3):452-460. doi: 10.1182/blood.2021013453.
7
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.
Lancet Haematol. 2021 Jan;8(1):e22-e33. doi: 10.1016/S2352-3026(20)30368-9. Epub 2020 Dec 5.
8
Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children.
Blood. 2020 Jan 16;135(3):220-226. doi: 10.1182/blood.2019002260.
9
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.
Blood. 2020 Feb 13;135(7):491-504. doi: 10.1182/blood.2019000998.
10
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5.
Zotero 插件